These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6200719)

  • 21. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
    Siegl PK; Morgan G; Sweet CS
    J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental changes in the interactions of amrinone and ouabain in canine ventricular muscle.
    Binah O; Rosen MR
    Dev Pharmacol Ther; 1983; 6(5):333-46. PubMed ID: 6628165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amrinone and energy output of rabbit papillary muscles.
    Gibbs CL; Wendt IR
    J Cardiovasc Pharmacol; 1985; 7(2):267-72. PubMed ID: 2581079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle.
    Kondo N; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(6):903-12. PubMed ID: 6196561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
    Alousi AA; Stankus GP; Stuart JC; Walton LH
    J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of action of the bipyridine milrinone on the heart.
    Farah AE; Frangakis CJ
    Basic Res Cardiol; 1989; 84 Suppl 1():85-103. PubMed ID: 2554875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.
    Wilmshurst PT; Thompson DS; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1983 Jan; 49(1):77-82. PubMed ID: 6821613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of isolated dog arteries to amrinone.
    Toda N; Nakajima M; Nishimura K; Miyazaki M
    Cardiovasc Res; 1984 Mar; 18(3):174-82. PubMed ID: 6584209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle.
    Morgan JP; Gwathmey JK; DeFeo TT; Morgan KG
    Circulation; 1986 Mar; 73(3 Pt 2):III65-77. PubMed ID: 3943182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of amrinone-induced positive inotropy in rabbit papillary muscles with depressed contractile function: effects on cyclic nucleotide levels and phosphodiesterase isoenzymes.
    Shahid M; Rodger IW
    J Pharm Pharmacol; 1991 Feb; 43(2):88-94. PubMed ID: 1672907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
    Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
    Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.
    Gwathmey JK; Morgan JP
    Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.
    Shahid M; Rodger IW
    Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of amrinone with endogenous adenosine in guinea-pig atria.
    Dorigo P; Maragno I
    Br J Pharmacol; 1986 Apr; 87(4):623-9. PubMed ID: 3708202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive inhibition of phosphodiesterase activity by amrinone: its implication in the cardiac effect of the drug.
    Carpenedo F; Floreani M; Cargnelli G
    Pharmacol Res Commun; 1984 Oct; 16(10):969-77. PubMed ID: 6095329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of MDL 19205 (piroximone), a new cardiotonic agent, on electrophysiological, mechanical, and intracellular ionic characteristics of sheep cardiac tissues.
    Wasserstrom JA
    J Cardiovasc Pharmacol; 1986; 8(3):596-606. PubMed ID: 2425179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.